Oral Posaconazole in High Risk Patients With Gastrointestinal Dysfunction (Study P05115)
Status:
Completed
Trial end date:
2009-04-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is: to explore the potential for different dosing strategies of
posaconazole oral suspension (POS) to increase plasma levels and to profile the
pharmacokinetics of these dosing strategies in patients with compromised gastrointestinal
function and at high risk for Invasive Fungal Infection.